Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
NCT04026997Phase 2Terminated
- Sponsor
- CinDome Pharma
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deudomperidone in gastroparesis, sponsored by CinDome Pharma. Started Sep 2019; status: terminated.
02
Drugs
deudomperidone
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04026997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026997.